| VERASTEM INC. NEW |
| USA |
| Gesundheit |
| US92337C2035 / A3EHM3 |
| 2VSA (Frankfurt) / VSTM (NASDAQ) |
| FRA:2VSA, ETR:2VSA, 2VSA:GR, NASDAQ:VSTM |
| - |
| https://www.verastem.com/ |
|
Verastem Inc. is a biopharmaceutical company that ..
>Volltext.. |
| 530.27 Mio. EUR |
| 462.53 Mio. EUR |
| 1.86 Mio. EUR |
| -136.12 Mio. EUR |
| -144.95 Mio. EUR |
| -2.85 EUR |
| 73.73 Mio. EUR |
| 143.01 Mio. EUR |
| -104.64 Mio. EUR |
| 3.26 |
| -80.57% |
| -69.23% |
| - |
| - |
| - |
| VERASTEM |
| 04.11.25 |
|